DE69028993T2 - Verwendung von kaffein bei der behandlung von herpes-simplex-virusinfektionen - Google Patents

Verwendung von kaffein bei der behandlung von herpes-simplex-virusinfektionen

Info

Publication number
DE69028993T2
DE69028993T2 DE69028993T DE69028993T DE69028993T2 DE 69028993 T2 DE69028993 T2 DE 69028993T2 DE 69028993 T DE69028993 T DE 69028993T DE 69028993 T DE69028993 T DE 69028993T DE 69028993 T2 DE69028993 T2 DE 69028993T2
Authority
DE
Germany
Prior art keywords
caffeine
treatment
herpes simplex
simplex virus
virus infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69028993T
Other languages
English (en)
Other versions
DE69028993D1 (de
Inventor
Michael Surtech Internat Potts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anca Health Care Ltd Banbury Oxon Gb
Original Assignee
Surtech International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Surtech International Ltd filed Critical Surtech International Ltd
Publication of DE69028993D1 publication Critical patent/DE69028993D1/de
Application granted granted Critical
Publication of DE69028993T2 publication Critical patent/DE69028993T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/05—Stick

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69028993T 1989-11-24 1990-11-23 Verwendung von kaffein bei der behandlung von herpes-simplex-virusinfektionen Expired - Fee Related DE69028993T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898926595A GB8926595D0 (en) 1989-11-24 1989-11-24 Pharmaceutical compositions for use in the treatment herpes simplex virus infections
PCT/GB1990/001819 WO1991007969A1 (en) 1989-11-24 1990-11-23 Use of caffeine in the treatment of herpes simplex virus infections

Publications (2)

Publication Number Publication Date
DE69028993D1 DE69028993D1 (de) 1996-11-28
DE69028993T2 true DE69028993T2 (de) 1997-02-20

Family

ID=10666857

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69028993T Expired - Fee Related DE69028993T2 (de) 1989-11-24 1990-11-23 Verwendung von kaffein bei der behandlung von herpes-simplex-virusinfektionen

Country Status (7)

Country Link
US (1) US5382436A (de)
EP (1) EP0502048B1 (de)
JP (1) JP3180221B2 (de)
AU (1) AU6748090A (de)
DE (1) DE69028993T2 (de)
GB (1) GB8926595D0 (de)
WO (1) WO1991007969A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ284920B6 (cs) * 1996-02-14 1999-04-14 Vladimír Prof. Mudr. Drsc. Vonka Preparáty pro léčbu rekurentního herpesu založené na potenciaci účinků syntetických virostatik kofeinem
US7585523B2 (en) * 2002-08-27 2009-09-08 Targeted Medical Pharma Composition and method to augment and sustain neurotransmitter production
US20040258765A1 (en) * 2003-06-23 2004-12-23 Gee Gilbert C. Method for treatment of sores and lesions of the skin
US7560465B2 (en) * 2005-03-31 2009-07-14 Richard Holschen Compositions and methods for delivery of caffeine
US20110142957A1 (en) * 2005-08-15 2011-06-16 Van Kempen Theo Method of treating parturient placental mammals in order to reduce maternal and/or uterine exhaustion
US7893070B2 (en) * 2005-08-15 2011-02-22 Provimi Holding B.V. Method of treating parturient placental mammals in order to reduce maternal and/or uterine exhaustion
US20070082035A1 (en) * 2005-10-06 2007-04-12 New York Blood Center, Inc. Anti-infective hygiene products based on cellulose acetate phthalate
KR20100005063A (ko) * 2006-09-18 2010-01-13 패트릭 티. 프렌더게스트 바이러스 감염을 치료하기 위한 스타틴 및 카페인을 포함하는 조성물
EP2489354A1 (de) * 2011-02-18 2012-08-22 Vironova AB Pharmazeutische Formulierung enthaltend B220 zur topischen Behandlung von Herpes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH523069A (de) * 1968-04-06 1972-05-31 Joos Bernhard Kosmetisches Hautbehandlungsmittel
US4132782A (en) * 1977-05-19 1979-01-02 Samuel Bean Method for suppressing herpes simplex virus
FR2499405A1 (fr) * 1981-02-10 1982-08-13 Biotherm Composition cosmetique amincissante et anti-cellulitique a base d'un extrait de plante contenant des saponines, un extrait d'arnica montana l. et d'un extrait de noix de cola et son procede d'application
GB8517301D0 (en) * 1985-07-09 1985-08-14 Salim A S M Synergistic biologically active substances
FR2609395B1 (fr) * 1988-02-23 1992-01-10 Serobiologiques Lab Sa Utilisation de bases xanthiques comme principe actif d'une composition pharmaceutique, notamment dermatologique, ou cosmetique, composition notamment utile comme matiere de base pour la preparation de composition pharmaceutique ou cosmetique et composition pharmaceutique ou cosmetique ainsi preparee
FR2639541B1 (fr) * 1988-11-29 1993-09-24 Fabre Pierre Cosmetique Amincissants topiques contenant des derives cafeines carboxyliques neutralises par des bases organiques et preparations utiles dans le traitement de la cellulite

Also Published As

Publication number Publication date
JPH05501564A (ja) 1993-03-25
GB8926595D0 (en) 1990-01-17
DE69028993D1 (de) 1996-11-28
WO1991007969A1 (en) 1991-06-13
AU6748090A (en) 1991-06-26
US5382436A (en) 1995-01-17
EP0502048B1 (de) 1996-10-23
JP3180221B2 (ja) 2001-06-25
EP0502048A1 (de) 1992-09-09

Similar Documents

Publication Publication Date Title
ATE110556T1 (de) Verbesserungen bei der behandlung von zähnen.
CY2006008I2 (el) Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines
MX9101237A (es) Xantinas substituidas y procedimiento para su preparacion
NO891369L (no) Fremstilling og anvendelse av kondenserte pyrimidiner.
DE69214283D1 (de) Verwendung von cellulase bei der zellstoffbehandlung
DE69028993T2 (de) Verwendung von kaffein bei der behandlung von herpes-simplex-virusinfektionen
FI932847A0 (fi) HIV-proteasinhibitorer som aer anvaendbara foer behandling av aids
DE59001142D1 (de) Acetale von oxo-tetralinen und von oxo-indanen.
MX9101235A (es) Xantinas substituidas y procedimiento para su preparacion
DK147088D0 (da) Middel til behandling af virale infektioner i mennesker
DK0538305T3 (da) Penciclovir og famciclovir og beslægtede guaninderivater til behandling af HIV-1-infektioner
DE69004451T2 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
DE69132782D1 (de) Verwendung von angiotensin-ii-antagonisten in der behandlung der linken ventrikulären hypertrophie
ATE142503T1 (de) Arzneimittelzubereitung bei der behandlung von tonsillitis
NO913774L (no) Cykloheksylfenylpyrimidiner, fremgangsmaate for fremstilling og anvendelse derav i vaeskekrystallinske blandinger
DE69523776T2 (de) Verwendung von aminopurinen antiviralen mitteln zur behandlung und prophylaxe der latenten herpes-virus infektionen
DE69030414D1 (de) Reinigung von Albumin
DE69117586D1 (de) Befestigung von steckbaren Stiften in keramischen Substraten
IT1239064B (it) Uso terapeutico del dipiridamolo
ZA888822B (en) Agents for removing human immunodeficiency virus and/or its related compounds
DE69218215D1 (de) Entfernung von schwefelwasserstoff
DE59003369D1 (de) Verwendung von Triacetin in Gleitmitteln.
DE69011627T2 (de) Entfernung und Identifizierung von komplex geladenen Einheiten.
FI982503A0 (fi) C3-C3-polyfluorialkaanien käyttö ponnekaasuina suihkuttimissa
DE3789760T2 (de) Orale Hyposensibilisierung bei der Behandlung von Allergien.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ANCA HEALTH CARE LTD., BANBURY, OXON, GB

8339 Ceased/non-payment of the annual fee